Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,460 | -12,380 | -59,810 | -45,320 | -31,440 |
| Depreciation Amortization | 7,690 | 860 | 7,150 | 3,750 | 2,480 |
| Other Working Capital | 16,710 | 24,190 | 58,520 | 1,610 | 4,350 |
| Other Operating Activity | 200 | 2,600 | -7,130 | -900 | -3,010 |
| Operating Cash Flow | $-860 | $15,270 | $-1,270 | $-40,860 | $-27,620 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -60 | -60 | 13,700 | -1,330 | -1,040 |
| Other Investing Activity | -280 | 0 | 28,300 | 41,490 | 32,040 |
| Investing Cash Flow | $-340 | $-60 | $42,000 | $40,160 | $31,000 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 9,160 | -20 | -1,190 | -1,450 | -800 |
| Financing Cash Flow | $9,160 | $-20 | $-1,190 | $-1,450 | $-800 |
| Exchange Rate Effect | -360 | -2,410 | -580 | -770 | -1,410 |
| Beginning Cash Position | 49,220 | 49,220 | 10,270 | 10,270 | 10,270 |
| End Cash Position | 56,810 | 61,990 | 49,220 | 7,340 | 11,430 |
| Net Cash Flow | $7,590 | $12,760 | $38,950 | $-2,920 | $1,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -860 | 15,270 | -1,270 | -40,860 | -27,620 |
| Free Cash Flow | -860 | 15,270 | -1,270 | -40,860 | -27,620 |